Ogasawara, Ken
Bristol-Myers Squibb (United States)
3 papers on CoChatORCID 0000-0002-4264-8927
Most cited papers
- Verified
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Abramson, J. S., Palomba, M. L., Gordon, L. I., Lunning, M. A., Wang, M., Arnason, J., Mehta, A., Purev, E., Maloney, D. G., Andreadis, C., et al. (2020) · The Lancet
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 2,430
- Verified
Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease
Fujimoto, H., Taguchi, J.-I., Imai, Y., Ayabe, S., Hashimoto, H., Kobayashi, H., Ogasawara, K., Aizawa, T., Yamakado, M., Nagai, R., et al. (2008) · European Heart Journal
Glutathione Transferases and PolymorphismsParaoxonase enzyme and polymorphisms
Cited by 84
- Verified
Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer
Ikeda, M., Takahashi, H., Kondo, S., Lahn, M. M. F., Ogasawara, K., Benhadji, K. A., Fujii, H., & Ueno, H. (2017) · Cancer Chemotherapy and Pharmacology
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 51
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free